GO
Loading...

Regeneron Pharmaceuticals Inc

More

  • FRANKFURT, Dec 15- Bayer's eye medication Eylea does not offer an advantage over a rival product from Novartis when treating patients with a type of diabetes-related swelling of the retina, a German healthcare cost watchdog said on Monday. IQWiG compared trial data on Eylea and Novartis's Lucentis for treatment of diabetic macular edema and found there was no...

  • Lightning Round: Time to buy buy buy for 2015 Thursday, 4 Dec 2014 | 6:50 PM ET

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Cramer's heated love affair with biotech Tuesday, 2 Dec 2014 | 6:33 PM ET
    File photo: Michael LeClair, left, and Kevin Fleurimond, in the manufacturing room of Biogen Idec.

    As the global economy faces headwinds each day, Jim Cramer knows this group can withstand stormy weather more often than the rest.

  • Cramer Remix: This industry isn't dead yet! Monday, 24 Nov 2014 | 7:08 PM ET

    A big positive sign in this once left-for-dead sector has turned Cramer's attention to a handful of stocks that could go higher.

  • Fighting kids' cancer, one voucher at a time Friday, 21 Nov 2014 | 10:03 AM ET
    Jacob with his parents Mike Froman and Nancy Goodman, and brother Ben (Spring 2008)

    There are few new cancer drugs to treat kids, and not much research is being done.

  • Midday movers: Allergan, CarMax, CBS & more Monday, 17 Nov 2014 | 1:03 PM ET

    Some of Monday's midday movers:

  • Cramer spotlight: These three sectors keep growing Tuesday, 11 Nov 2014 | 6:05 PM ET
    Traders on the floor of the New York Stock Exchange.

    Think that the market was uneventful on Tuesday? Not so fast, Jim Cramer sees these three sectors growing fast, which could lead to profits.

  • Midday movers: Comcast, Macy's, Xerox & more Tuesday, 11 Nov 2014 | 12:54 PM ET

    Some of Tuesday's midday movers:

  • *Alibaba rises after results, Priceline falls. NEW YORK, Nov 4- The S&P 500 and Nasdaq ended lower on Tuesday as another big drop in oil prices dragged down energy shares and Priceline's earnings forecast disappointed. The S&P 500 energy sector fell 1.9 percent, extending the group's recent drop, the Energy Select Sector SPDR ETF dropped 2.1 percent, and Chevron...

  • *Alibaba rises after results, Priceline falls. NEW YORK, Nov 4- The S&P 500 and Nasdaq ended lower on Tuesday as another big drop in oil prices dragged down energy shares and Priceline's earnings forecast disappointed. The S&P 500 energy sector fell 1.9 percent, extending the group's recent drop, the Energy Select Sector SPDR ETF dropped 2.1 percent, and Chevron...

  • US STOCKS-Wall St falls as energy continues slide Tuesday, 4 Nov 2014 | 12:20 PM ET

    *Alibaba rises after results, Priceline falls. U.S. crude oil fell 2.9 percent to $76.46 per barrel, dropping to its lowest level in about three years after Saudi Arabia cut sales prices to the United States. The Energy Select Sector SPDR ETF fell 2.3 percent to $84.09, while Chevron Corp fell 1.3 percent to $115.32.

  • *Alibaba rises after results, Priceline falls. NEW YORK, Nov 4- U.S. stocks fell in a broad decline on Tuesday, with energy shares leading the selloff as crude prices declined for a fourth straight day, raising concerns about global demand. U.S. crude oil fell 2.7 percent to $76.64 per barrel, dropping to its lowest level in about three years after Saudi Arabia cut sales...

  • *Alibaba rises after results, Priceline falls. NEW YORK, Nov 4- U.S. stocks fell on Tuesday, with energy shares leading the market lower as crude oil prices declined for a fourth straight day, though major indexes remained near record levels. U.S. crude fell 2 percent to $77.24 per barrel, dropping to its lowest level in about three years after Saudi Arabia cut sales...

  • NEW YORK, Nov 4- U.S. stock index futures pointed to a lower open on Tuesday, with investors taking a pause following a rally that has taken major indexes to repeated records, although a sharp decline in crude oil prices could weigh on energy shares. Energy companies will be in focus as U.S. crude futures slumped 2.3 percent to $76.87 per barrel after top oil exporter...

  • Early Movers: BABA, DISH, CVS, TIME, JPM & more Tuesday, 4 Nov 2014 | 8:06 AM ET

    Some of the names on the move ahead of the open.

  • Nov 4- Regeneron Pharmaceuticals Inc cut the top end of its full-year sales forecast for its blockbuster eye drug and reported a lower-than-expected adjusted quarterly profit, citing higher costs. Regeneron's net profit fell to $79.7 million, or 70 cents per share, in the third quarter ended Sept. 30 from $141.3 million, or $1.25 per share, a year earlier.

  • Nov 4- Regeneron Pharmaceuticals Inc reported a higher quarterly revenue on increased sales of its eye injection Eylea. The biotechnology company's net profit fell to $79.7 million, or 70 cents per share, in the third quarter Sept. 30, from $141.3 million, or $1.25 per share, a year earlier. Revenue rose 21.6 percent to $725.8 million and included collaboration...

  • Cramer's secret oil strategy: Unlock profits Monday, 27 Oct 2014 | 6:12 PM ET
    Jim Cramer on Mad Money.

    Jim Cramer shares his tricks of the trade on how to benefit from the low price of oil, and how to pick the right stocks in a dazed and confused market

  • What's boosting healthiest sector in S&P this year Monday, 27 Oct 2014 | 1:43 PM ET

    Health care has been on a tear in 2014, and there is still room for upside. Wall Street analysts are focusing on the following four trends.

  • Midday movers: Aeropostale, Netflix, Textron & more Friday, 17 Oct 2014 | 1:18 PM ET

    Some of Friday's midday movers: